Skip to main content

Table 3 Primary and secondary outcomes

From: The efficacy and safety of Shenzhu Guanxin Recipe Granules for the treatment of patients with coronary artery disease: protocol for a double-blind, randomized controlled trial

Primary endpoints Coronary Artery Calcification Score, change of area of non-calcified plaque, and the proportion of non-calcified plaques to total plaques
Secondary endpoints 1. Concentration of gene ABCA1, and TNF-α, IL-1, IL-6
2. Level of serum lipids
3. Level of high-sensitivity C-reactive protein (CRP)
4. Seattle Angina Questionnaire (SAQ) score
5. Change of Traditional Chinese Medicine (TCM) syndrome
6. Evaluation of occurrence and nature of major adverse cardiac events (MACE)
  1. Note: ABCA1 ATP-binding membrane cassette transporter A1, TNF-α  tumor necrosis factor-α, IL-1 interleukin-1, IL-6 interleukin-6